Skip to main content
Synthaverse S.A. logo

Synthaverse S.A. — Investor Relations & Filings

Ticker · BML ISIN · PLBMDLB00018 LEI · 259400OWZM67D079S374 WAR Manufacturing
Open in API
Filings indexed 180 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country PL Poland
Listing WAR BML

About Synthaverse S.A.

https://synthaverse.com/en/

Synthaverse S.A. is a pharmaceutical and biotechnology company that develops, manufactures, and delivers innovative medical products, including medicinal preparations, medical devices, and laboratory reagents. With a history of nearly 100 years, the company focuses on immunotherapies and leverages its own proprietary technologies. Key products include Onko BCG, a drug for bladder cancer, and the BCG 10 anti-tuberculosis vaccine. Synthaverse collaborates with scientific centers to advance its research and development, aiming to meet global quality standards and push the boundaries of medicine.

Recent filings

Filing Released Lang Actions
Otrzymanie istotnej informacji o rejestracji na terytorium Serbii produktu leczniczego na bazie dossier rejestracyjnego Onko BCG - Content (PL)
Regulatory Filings Classification · 85% confidence The document is a Polish ‘raport bieżący’ (current regulatory report) notifying investors about receiving a marketing authorization in Serbia. It contains operational news rather than financial statements, management changes, or capital activities. It does not present a full annual or interim report and is not simply announcing another report’s publication. This matches the definition of a general regulatory announcement. Therefore, it should be classified as Regulatory Filings (RNS).
2026-05-14 Polish
zal03_JW.pdf
Director's Dealing Classification · 92% confidence The document is a notification of a transaction by a management board member under MAR Article 19, detailing the insider purchase of shares (quantity, price, date, place). This corresponds to a director’s dealing / insider transaction report.
2026-05-13 Polish
zal05_KM.pdf
Director's Dealing Classification · 90% confidence The document is a notification under Article 19(1) of the EU Market Abuse Regulation (MAR) disclosing an insider transaction by a member of the supervisory board (Konrad Miterski) including share series, volume, price, date, and venue. This matches the definition of a Director’s Dealing report.
2026-05-13 Polish
zal04_DK.pdf
Director's Dealing Classification · 92% confidence The document is a regulatory notification under MAR article 19 by a member of the supervisory/management board reporting an acquisition of shares (insider transaction). This matches the definition for Director’s Dealing disclosures.
2026-05-13 Polish
zal01_WS.pdf
Director's Dealing Classification · 98% confidence The document is a notification of transactions by a person discharging managerial responsibilities under Article 19(1) of the EU Market Abuse Regulation (MAR), detailing the acquisition of company shares by a supervisory board member. This is a classic insider/director dealing filing. It fits the definition of Director’s Dealing (Code: DIRS).
2026-05-13 Polish
zal06_WN.pdf
Director's Dealing Classification · 90% confidence The document is a notification under Article 19(1) of the MAR regulation detailing an insider (Wiceprzewodniczący Rady Nadzorczej) acquiring company shares. It is a personal transaction by a management person, fitting the Director’s Dealing category rather than a corporate buyback.
2026-05-13 Polish

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.